![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Catco Reinsurance Opportunities Fund Limited | LSE:CAT | London | Ordinary Share | BMG1961Q3242 | ORD USD0.00013716 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 24.00 | 13.00 | 35.00 | 24.00 | 24.00 | 24.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Unit Inv Tr, Closed-end Mgmt | 6.33M | 5.44M | 3.6440 | 6.59 | 35.84M |
RNS No 9853n CAMBRIDGE ANTIBODY TECHNOLOGY GROUP 22nd December 1997 On December 19 1997 the Company issued an additional 14,982 10p ordinary shares (approximately 0.07% of the existing shareholding) to its wholly owned subsidiary CAT Group Employees' Trustees Limited the Corporate Trustee of an Inland Revenue approved Staff Share Scheme. The Corporate Trustee will hold the shares for the benefit of the eligible employees pursuant to the terms of the Scheme. The Directors of CAT Group Employees' Trustee Limited are John Aston Peter Garland and Sir Aaron Klug all of whom are also directors of Cambridge Antibody Technology plc. A separate announcement has been made today regarding the shareholding of Executive Directors as a result of operation of the Scheme. END MSCNFAAAAAXXFFN
1 Year Catco Reinsurance Opport... Chart |
1 Month Catco Reinsurance Opport... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions